Ibiayi Dagogo‐Jack

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer

Justin F. Gainor, Leila Dardaei, Satoshi Yoda et al. · Cancer Discovery · 2016 · 1.1K citations · Full text

Impact of <i>EML4-ALK</i> Variant on Resistance Mechanisms and Clinical Outcomes in <i>ALK</i>-Positive Lung Cancer

Viola W. Zhu, Satoshi Yoda, Beow Y. Yeap et al. · Journal of Clinical Oncology · 2018 · 313 citations · Full text

Lymphoid Neoplasia, Alk-positive Nsclc, Medicine +15

Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound <i>ALK</i> Mutations in ALK-Positive Lung Cancer

Satoshi Yoda, Michael S. Lawrence, Benjamin J. Burke et al. · Cancer Discovery · 2018 · 298 citations · Full text

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

David Shih, Naema Nayyar, Ivanna V. Bihun et al. · Nature Genetics · 2020 · 292 citations · Full text

Tumor Heterogeneity, Medicine, Metastatic Lung Adenocarcinoma +10

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non–Small-Cell Lung Cancer

Justin F. Gainor, Diane Tseng, Satoshi Yoda et al. · JCO Precision Oncology · 2017 · 255 citations